A detailed history of Great West Life Assurance CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 1,809,036 shares of GILD stock, worth $121 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,809,036
Previous 1,787,812 1.19%
Holding current value
$121 Million
Previous $144 Million 8.01%
% of portfolio
0.27%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $1.52 Million - $1.85 Million
21,224 Added 1.19%
1,809,036 $133 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $2.16 Million - $2.45 Million
-29,436 Reduced 1.62%
1,787,812 $144 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $494,954 - $540,004
6,694 Added 0.37%
1,817,248 $136 Million
Q2 2023

Aug 10, 2023

BUY
$76.01 - $86.7 $14.6 Million - $16.6 Million
191,686 Added 11.84%
1,810,554 $140 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $3.54 Million - $4.03 Million
45,794 Added 2.91%
1,618,868 $135 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $25 Million - $35.9 Million
-401,689 Reduced 20.34%
1,573,074 $136 Million
Q3 2022

Nov 01, 2022

SELL
$59.54 - $68.01 $2 Million - $2.28 Million
-33,544 Reduced 1.67%
1,974,763 $122 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $116 Million - $131 Million
2,008,307 New
2,008,307 $124 Million
Q2 2022

Aug 09, 2022

SELL
$57.72 - $65.01 $117 Million - $132 Million
-2,028,538 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$57.92 - $72.58 $6.43 Million - $8.06 Million
111,090 Added 5.79%
2,028,538 $127 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $13.3 Million - $15.1 Million
204,648 Added 11.95%
1,917,448 $139 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $1.62 Million - $1.75 Million
23,984 Added 1.42%
1,712,800 $120 Million
Q2 2021

Aug 11, 2021

SELL
$63.47 - $69.35 $9.55 Million - $10.4 Million
-150,416 Reduced 8.18%
1,688,816 $116 Million
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $20.6 Million - $23.5 Million
-342,908 Reduced 15.71%
1,839,232 $118 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $5.95 Million - $6.78 Million
104,971 Added 5.05%
2,182,140 $127 Million
Q3 2020

Nov 17, 2020

SELL
$62.1 - $78.08 $4.74 Million - $5.95 Million
-76,262 Reduced 3.54%
2,077,169 $131 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $4.53 Million - $5.69 Million
72,899 Added 3.5%
2,153,431 $136 Million
Q2 2020

Aug 17, 2020

SELL
$72.34 - $84.0 $7.94 Million - $9.22 Million
-109,754 Reduced 5.01%
2,080,532 $160 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $993,374 - $1.27 Million
15,861 Added 0.73%
2,190,286 $165 Million
Q4 2019

Feb 11, 2020

BUY
$61.62 - $67.78 $19.5 Million - $21.4 Million
315,662 Added 16.98%
2,174,425 $141 Million
Q3 2019

Oct 25, 2019

BUY
$62.51 - $69.0 $2.84 Million - $3.13 Million
45,394 Added 2.5%
1,858,763 $118 Million
Q2 2019

Jul 31, 2019

SELL
$61.87 - $69.38 $378,396 - $424,328
-6,116 Reduced 0.34%
1,813,369 $0
Q1 2019

May 08, 2019

BUY
$62.53 - $70.05 $11.3 Million - $12.7 Million
181,393 Added 11.07%
1,819,485 $118 Million
Q4 2018

Feb 12, 2019

SELL
$60.54 - $79.0 $16.4 Million - $21.4 Million
-270,402 Reduced 14.17%
1,638,092 $99.1 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $9.52 Million - $10.5 Million
-133,568 Reduced 6.54%
1,908,494 $148 Million
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $6.52 Million - $7.61 Million
100,519 Added 5.18%
2,042,062 $145 Million
Q1 2018

May 10, 2018

SELL
$72.84 - $88.8 $2.64 Million - $3.21 Million
-36,198 Reduced 1.83%
1,941,543 $147 Million
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $10 Million - $11.8 Million
141,241 Added 7.69%
1,977,741 $141 Million
Q3 2017

Nov 09, 2017

BUY
$72.11 - $85.47 $132 Million - $157 Million
1,836,500
1,836,500 $148 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.